Mira D. Franken

Nijmegen, GE, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Real-world comparison of avelumab maintenance versus pembrolizumab at progression after first-line platinum-based chemotherapy in metastatic urothelial cancer.

Real-world comparison of avelumab maintenance versus pembrolizumab at progression after first-line platinum-based chemotherapy in metastatic urothelial cancer.

Journal: ESMO real world data and digital oncology

Published: April 03, 2026

Treatments and survival outcomes of patients with synchronous and metachronous metastatic bladder cancer: A population-based nationwide cohort study.

Treatments and survival outcomes of patients with synchronous and metachronous metastatic bladder cancer: A population-based nationwide cohort study.

Journal: Cancer treatment and research communications

Published: November 03, 2025

Multimodal integration of blood RNA and ctDNA reflects response to immunotherapy in metastatic urothelial cancer.

Multimodal integration of blood RNA and ctDNA reflects response to immunotherapy in metastatic urothelial cancer.

Journal: JCI insight

Published: January 30, 2025

Pembrolizumab after platinum-based chemotherapy for metastatic urothelial cancer: comparison between patients from a Dutch nationwide cohort and KEYNOTE-045.

Pembrolizumab after platinum-based chemotherapy for metastatic urothelial cancer: comparison between patients from a Dutch nationwide cohort and KEYNOTE-045.

Journal: Cancer treatment and research communications

Published: December 13, 2024

Model-informed development of a cost-saving dosing regimen for enfortumab vedotin.

Model-informed development of a cost-saving dosing regimen for enfortumab vedotin.

Journal: Cancer chemotherapy and pharmacology

Published: November 27, 2024

Ipilimumab with nivolumab in molecularly selected patients with castration-resistant prostate cancer: primary analysis of the phase II INSPIRE trial.

Ipilimumab with nivolumab in molecularly selected patients with castration-resistant prostate cancer: primary analysis of the phase II INSPIRE trial.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: August 13, 2024

Folate, folic acid, and chemotherapy-induced toxicities: A systematic literature review.

Folate, folic acid, and chemotherapy-induced toxicities: A systematic literature review.

Journal: Critical reviews in oncology/hematology

Published: April 21, 2023

Work Ability in Patients With Stage I to IV Colon Cancer: Results of the Dutch Prospective Colorectal Cancer Cohort.

Work Ability in Patients With Stage I to IV Colon Cancer: Results of the Dutch Prospective Colorectal Cancer Cohort.

Journal: Diseases of the colon and rectum

Published: November 10, 2021

Comparing Modeling Approaches for Discrete Event Simulations With Competing Risks Based on Censored Individual Patient Data: A Simulation Study and Illustration in Colorectal Cancer.

Comparing Modeling Approaches for Discrete Event Simulations With Competing Risks Based on Censored Individual Patient Data: A Simulation Study and Illustration in Colorectal Cancer.

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Published: February 05, 2021

Evaluation of the performance of algorithms mapping EORTC QLQ-C30 onto the EQ-5D index in a metastatic colorectal cancer cost-effectiveness model.

Evaluation of the performance of algorithms mapping EORTC QLQ-C30 onto the EQ-5D index in a metastatic colorectal cancer cost-effectiveness model.

Journal: Health and quality of life outcomes

Published: March 05, 2020

Comparing Strategies for Modeling Competing Risks in Discrete-Event Simulations: A Simulation Study and Illustration in Colorectal Cancer.

Comparing Strategies for Modeling Competing Risks in Discrete-Event Simulations: A Simulation Study and Illustration in Colorectal Cancer.

Journal: Medical decision making : an international journal of the Society for Medical Decision Making

Published: February 26, 2019

Matching the model with the evidence: comparing discrete event simulation and state-transition modeling for time-to-event predictions in a cost-effectiveness analysis of treatment in metastatic colorectal cancer patients.

Matching the model with the evidence: comparing discrete event simulation and state-transition modeling for time-to-event predictions in a cost-effectiveness analysis of treatment in metastatic colorectal cancer patients.

Journal: Cancer epidemiology

Published: June 08, 2018

Showing 1-12 of 15

Last Updated: 09/26/2026